Skip to Main Content

Paper Details

Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: <i>In Vitro</i> Activity against SARS-CoV-2 and Potential Mechanisms.
ACS Omega
51
2021
-ACE2 cells, A549, A549-ACE2, A549-ACE2 cells, ACE2, Caco-2, Calu-3, EBOV, EBOVs, Ebola, Ebola and Marburg Virus, Ebola and Marburg viruses, Ebola viruses, HCoV 229E, HUH-, HeLa, HeLa cells, Human, MHV, Pyronaridine, Quinacrine, RNA polymerase, SARS, SARS-CoV, SARS-CoV-2, Severe acute respiratory coronavirus 2, Tilorone, Vero76, VeroE6, cell lines, humans, influenza, malaria, mice, monocytes, mouse, pyronaridine, quinacrine, remdesivir, tilorone
Author NameAffiliation
Boyd L YountUniversity of North Carolina School of Medicine
Stuart WestonUniversity of Maryland School of Medicine
James LogueUniversity of Maryland School of Medicine
Matthew B FriemanUniversity of Maryland School of Medicine
Matthew B FriemanUniversity of Maryland School of Medicine
Ralph S BaricUniversity of North Carolina School of Medicine
Ralph S BaricUniversity of North Carolina School of Medicine
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina School of Medicine
Ralph S BaricUniversity of North Carolina School of Medicine
Ralph S BaricUniversity of North Carolina at Chapel Hill
  • 1 - 11

Datasets

Release 1.2